Mechanical cardiac support 2000: current applications and future trial design. June 15-16, 2000 Bethesda, Maryland (Q34128486)

31 July 2017

1 reference

title

Mechanical cardiac support 2000: current applications and future trial design. June 15-16, 2000 Bethesda, Maryland (English)

1 reference

31 July 2017

Stevenson LW

1

1 reference

31 July 2017

Kormos RL

2

1 reference

31 July 2017

Bourge RC

3

1 reference

31 July 2017

Gelijns A

4

1 reference

31 July 2017

Griffith BP

5

1 reference

31 July 2017

Hershberger RE

6

1 reference

31 July 2017

Hunt S

7

1 reference

31 July 2017

Kirklin J

8

1 reference

31 July 2017

Miller LW

9

1 reference

31 July 2017

Pae WE Jr

10

1 reference

31 July 2017

Pantalos G

11

1 reference

31 July 2017

Pennington DG

12

1 reference

31 July 2017

Rose EA

13

1 reference

31 July 2017

Watson JT

14

1 reference

31 July 2017

Willerson JT

15

1 reference

31 July 2017

Young JB

16

1 reference

31 July 2017

Barr ML

17

1 reference

31 July 2017

Costanzo MR

18

1 reference

31 July 2017

Desvigne-Nickens P

19

1 reference

31 July 2017

Feldman AM

20

1 reference

31 July 2017

Frazier OH

21

1 reference

31 July 2017

Friedman L

22

1 reference

31 July 2017

Hill JD

23

1 reference

31 July 2017

Konstam MA

24

1 reference

31 July 2017

McCarthy PM

25

1 reference

31 July 2017

Michler RE

26

1 reference

31 July 2017

Oz MC

27

1 reference

31 July 2017

Rosengard BR

28

1 reference

31 July 2017

Sapirstein W

29

1 reference

31 July 2017

Shanker R

30

1 reference

31 July 2017

Smith CR

31

1 reference

31 July 2017

Starling RC

32

1 reference

31 July 2017

Taylor DO

33

1 reference

31 July 2017

Wichman A

34

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Journal of the American College of Cardiology

31 July 2017

published in

1 reference

31 July 2017

volume

37

1 reference

31 July 2017

issue

1

1 reference

31 July 2017

page(s)

340-370

1 reference

31 July 2017

cites work

Cardiac assist devices.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Clinical experience with 111 thoratec ventricular assist devices

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Improved survival rates support left ventricular assist device implantation early after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Improved survival in patients with acute myocarditis using external pulsatile mechanical ventricular assistance

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Worldwide experience with the TCI HeartMate system: issues and future perspective

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

The European experience of Novacor left ventricular assist (LVAS) therapy as a bridge to transplant: a retrospective multi-centre study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Factors influencing HLA sensitization in implantable LVAD recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

The REMATCH trial: rationale, design, and end points

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Measurement of health state utilities for economic appraisal

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Evolving concepts of heart failure: cooling furnace, malfunctioning pump, enlarging muscle--Part I.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Evolving concepts of heart failure: cooling furnace, malfunctioning pump, enlarging muscle. Part II: Hypertrophy and dilatation of the failing heart.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Withdrawal of digoxin from patients with chronic heart failure treated with angiotensin-converting-enzyme inhibitors. RADIANCE Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

The effect of digoxin on mortality and morbidity in patients with heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Effects of diuretic therapy on the development of tolerance to nitroglycerin and exercise capacity in patients with chronic stable angina

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Extracorporeal assistance to the circulation and intraaortic balloon pumping

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Results of coronary artery surgery in patients with poor left ventricular function (CASS).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Treatment of chronic stable angina. A preliminary report of survival data of the randomized Veterans Administration cooperative study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Twelve-year follow-up of survival in the randomized European Coronary Surgery Study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

A randomized evaluation of early revascularization to treat shock complicating acute myocardial infarction. The (Swiss) Multicenter Trial of Angioplasty for Shock-(S)MASH.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

The Registry of the International Society for Heart and Lung Transplantation: sixteenth official report--1999

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

APACHE II score and mortality in respiratory failure due to cardiogenic pulmonary edema

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

APACHE II, data accuracy and outcome prediction

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Contemporary reperfusion therapy for cardiogenic shock: The GUSTO-I trial experience

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Current spectrum of cardiogenic shock and effect of early revascularization on mortality. Results of an International Registry. SHOCK Registry Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Cardiogenic shock complicating acute myocardial infarction: predictors of death. GUSTO Investigators. Global Utilization of Streptokinase and Tissue-Plasminogen Activator for Occluded Coronary Arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Development and prospective validation of a clinical index to predict survival in ambulatory patients referred for cardiac transplant evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Freedom from congestion predicts good survival despite previous class IV symptoms of heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

A decade of clinical trial developments in postmyocardial infarction, congestive heart failure, and sustained ventricular tachyarrhythmia patients: from CAST to AVID and beyond. Cardiac Arrhythmic Suppression Trial. Antiarrhythmic Versus Implantable

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Circulatory support for myocardial infarction with ventricular arrhythmias

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Control of Refractory Ventricular Tachycardia with Biventricular Assist Devices

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Management of recurrent ventricular tachycardia with ventricular assist device placement

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Efficacy of coronary stenting in the management of cardiac allograft vasculopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Cardiac transplant coronary artery disease. A multivariable analysis of pretransplantation risk factors for disease development and morbid events.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Screening Scale Predicts Patients Successfully Receiving Long-term Implantable Left Ventricular Assist Devices

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

100 long-term implantable left ventricular assist devices: the Columbia Presbyterian interim experience

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Transplant candidate's clinical status rather than right ventricular function defines need for univentricular versus biventricular support

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Selection criteria for placement of left ventricular assist devices

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Quality of life with an implanted left ventricular assist device.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Target Heart Failure Populations for Newer Therapies

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Measuring quality of life for patients with terminal illness: the Missoula-VITAS quality of life index

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

The last six months of life for patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Equipoise and the ethics of clinical research

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Of mice but not men. Problems of the randomized clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

How to resolve an ethical dilemma concerning randomized clinical trials.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Understanding controlled trials. What is a patient preference trial?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Incorporating patient preferences into randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Patient preferences and randomised clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Are randomized controlled trials controlled? Patient preferences and unblind trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Early ambulation after 5 French diagnostic cardiac catheterization: results of a multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

A comparison of observational studies and randomized, controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Randomized, controlled trials, observational studies, and the hierarchy of research designs

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Randomized trials or observational tribulations?

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Clinical and prophylactic trials with assured new treatment for those at greater risk: I. A design proposal.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Long-term mechanical circulatory support system reliability recommendation: American Society for Artificial Internal Organs and The Society of Thoracic Surgeons: long-term mechanical circulatory support system reliability recommendation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Development of the Nimbus/Pittsburgh axial flow left ventricular assist system

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Durability testing of components for the Jarvik 2000 completely implantable axial flow left ventricular assist device

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Miniature axial flow pump for ventricular assistance in children and small adults

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

First clinical experience with the DeBakey VAD continuous-axial-flow pump for bridge to transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

AB-180 circulatory support system: summary of development and phase I clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

Steady state hemodynamic and energetic characterization of the Penn State/3M Health Care Total Artificial Heart.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2800%2901099-8

7 January 2021

10.1016/S0735-1097(00)01099-8

Identifiers

DOI

1 reference

31 July 2017

1 reference